EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The impact of a potassium-enriched salt substitute on blood pressure control in patients with resistant arterial hypertension: A randomized pilot trial

Enilson Carmo Barbosa Dos Santos, Yasmin de Souza Lima Bitar, Jorge Luís Motta Dos Anjos, Cristiano Ricardo Bastos de Macedo, Apoenna Marina Noronha Brito, Marina Pereira Ferreira, Tomaz Mattedi Carvalho, Gabriele Eliza Assis, Jackson Pedro Barros Pereira, Ana Beatriz Cazé Ceron, Victoria Bastos Rodrigues, Leonardo Roever und 1 weitere

Contemporary Clinical Trials · 2026

DOI: 10.1016/j.cct.2026.108230 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2026. Verfasst von Enilson Carmo Barbosa Dos Santos und 12 weiteren Autor:innen. Beteiligte Einrichtung: Federal University of Bahia (UFBA), Salvador, BA, Brazil; Professor Edgard Santos University Hospital (HUPES), Federal University of Bahia (UFBA), Sa…. Hauptthemen laut MEDLINE: Hypertension, Potassium Chloride, Sodium Chloride, Dietary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Dietary sodium reduction and potassium enrichment are recommended non-pharmacological strategies for blood pressure (BP) control; however, randomized evidence evaluating potassium-enriched salt substitutes specifically in patients with resistant arterial hypertension (RAH) remains limited. METHODS: We conducted a randomized, double-blind, controlled pilot trial including adults with RAH. Participants were assigned to receive either a potassium-enriched salt substitute (approximately 50% sodium chloride and 50% potassium chloride) or regular salt for 24 weeks. The primary outcome was the between-group difference in change in 24-h systolic BP assessed by ambulatory blood pressure monitoring (ABPM). The primary analyses used an available-case approach (completers) to prioritize analytical rigor, with intention-to-treat and sensitivity analyses assessing robustness. Between-group comparisons were utilized to control for regression to the mean and white-coat variability. RESULTS: Among 60 randomized participants, 49 completed valid baseline and follow-up ABPM assessments (23 intervention, 26 control). At 24 weeks, patients assigned to potassium-enriched salt exhibited a directionally greater reduction in 24-h systolic blood pressure compared with the control group, resulting in a between-group difference of -2.47 mmHg (95% CI -4.93 to 0.00; P = 0.05). A similar directional pattern was observed for diastolic blood pressure. Office blood pressure measurements showed greater variability and less consistent between-group differences over time. Urinary potassium excretion increased in the intervention group, whereas changes in urinary sodium excretion were modest. No cases of clinically relevant hyperkalemia or serious adverse events were observed. CONCLUSIONS: In this randomized pilot trial, the use of a potassium-enriched salt substitute was safe and associated with modest, directionally greater reductions in ambulatory BP compared with regular salt in patients with RAH. These findings support the feasibility and safety of potassium-enriched salt substitution as a pragmatic adjunctive strategy for blood pressure management in patients with resistant hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionPotassium ChlorideSodium Chloride, DietaryHumansPilot ProjectsFemaleMiddle AgedDouble-Blind MethodBlood Pressure Monitoring, AmbulatoryMaleBlood PressureAged

Stichwörter der Autor:innen

Ambulatory blood pressure monitoringRandomized clinical trialResistant hypertensionSalt substitute

Substanzen

Potassium ChlorideSodium Chloride, Dietary

Autor:innen und Institutionen

  • Federal University of Bahia (UFBA), Salvador, BA, Brazil; Professor Edgard Santos University Hospital (HUPES), Federal University of Bahia (UFBA), Salvador, BA, Brazil; Roberto Santos General Hospital (HGRS), Salvador,…
  • Roberto Santos General Hospital (HGRS), Salvador, BA, Brazil.
  • Federal University of Bahia (UFBA), Salvador, BA, Brazil; Professor Edgard Santos University Hospital (HUPES), Federal University of Bahia (UFBA), Salvador, BA, Brazil.
  • Bahia State Health Department, Brazil.
  • Federal University of Uberlandia, Brazil.

Zitieren

APA

Dos Santos, E. C. B., de Souza Lima Bitar, Y., Dos Anjos, J. L. M., de Macedo, C. R. B., Brito, A. M. N., Ferreira, M. P., Carvalho, T. M., Assis, G. E., Pereira, J. P. B., Ceron, A. B. C., Rodrigues, V. B., Roever, L., & Durães, A. R. (2026). The impact of a potassium-enriched salt substitute on blood pressure control in patients with resistant arterial hypertension: A randomized pilot trial. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2026.108230

Vancouver

Dos Santos ECB, de Souza Lima Bitar Y, Dos Anjos JLM, de Macedo CRB, Brito AMN, Ferreira MP, et al. The impact of a potassium-enriched salt substitute on blood pressure control in patients with resistant arterial hypertension: A randomized pilot trial. Contemporary Clinical Trials. 2026. doi:10.1016/j.cct.2026.108230

BibTeX
@article{DosSantos2026,
  author = {Dos Santos, Enilson Carmo Barbosa and de Souza Lima Bitar, Yasmin and Dos Anjos, Jorge Luís Motta and de Macedo, Cristiano Ricardo Bastos and Brito, Apoenna Marina Noronha and Ferreira, Marina Pereira and Carvalho, Tomaz Mattedi and Assis, Gabriele Eliza and Pereira, Jackson Pedro Barros and Ceron, Ana Beatriz Cazé and Rodrigues, Victoria Bastos and Roever, Leonardo and Durães, André Rodrigues},
  title = {The impact of a potassium-enriched salt substitute on blood pressure control in patients with resistant arterial hypertension: A randomized pilot trial},
  journal = {Contemporary Clinical Trials},
  year = {2026},
  doi = {10.1016/j.cct.2026.108230}
}
Kostenlos starten →